This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)--Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious ...

The article provides an investment overview of Arcutus, offering insights and analysis, and ways of thinking about the investment opportunity. Arcutus is an mRNA specialist developer with no approved ...

With top-and-bottom-line beats for the most recent quarter, Arcturus Therapeutics (ARCT) is making progress in unleashing the power of mRNA to revolutionize treatments for infectious diseases, liver ...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease ...

A new Covid variant dubbed Arcturus which is driving a surge of fresh cases in India seems to have some unique symptoms in children, experts have pointed out. The XBB.1.16 strain, a sub-variant of ...